Good News! EClinCloud Named to the 2025 China Healthcare Digitalization Top 20

Recently, at a thousand-attendee conference hosted by EqualOcean and focused on AI-driven industrial transformation, the "WIM2025 Innovators Annual Conference," the closely watched annual list, "2025 China Healthcare Digitalization Top 20," was officially released. EClinCloud was selected for its AI innovation achievements, marking renewed authoritative recognition of the company's leading AI capabilities in clinical research. The list highlights companies' digital enablement value in healthcare settings.
In 2025, EClinCloud continued to advance AI technological innovation. Through technological innovation and clinical trial endpoint assessment technologies, combined with the deepening integration of AI computing power, algorithms, and large models into clinical operational settings, the company has built an integrated intelligent cloud platform covering the full clinical trial lifecycle, enabling end-to-end intelligent collaboration from data capture and intelligent analysis to decision support.
In addition to being selected for "2025 China Healthcare Digitalization Enterprises Top 20," EClinCloud has successively won the following this year:
January
:
Excellence Award at the Chengdu International Software Design and Application Competition
February
:
First Place in the Alibaba Cloud Tianchi Lab Benchmark Competition
April: First Prize, Inaugural AI-Enabled Industry Competition
April: 2025 Zhejiang Top 100 Seed Unicorn Enterprises
July: Excellence Award, 14th China Innovation and Entrepreneurship Competition (2025)
November: Quality Suppliers in China's Pharmaceutical Industry 100
Meanwhile, with its industry-leading digital clinical research solutions, the company has received successive coverage from mainstream and specialized media outlets such as Ningbo Daily and VCBeat, and its influence has continued to grow.
Behind these honors lies the industry's recognition of EClinCloud's professional capabilities and continuous innovation. Going forward, with AI innovation as our engine, we will continue to deepen the integration of AI technology with digital and intelligent clinical research practices, enhance our product and service capabilities, and advance the intelligent upgrading of clinical research.


